Literature DB >> 10217380

Review of methods to determine VA health care costs.

P G Barnett1.   

Abstract

BACKGROUND: Estimates of health care cost are needed to conduct cost-effectiveness research at the facilities operated by the US Department of Veterans Affairs.
METHODS: The medical literature was searched for VA studies to characterize different cost methods and identify their advantages and disadvantages.
RESULTS: Different methods are appropriate for different studies. Analysts who wish to capture the effect of an intervention on resources used in a health care encounter may wish to create a detailed pseudo-bill by combining VA utilization data with unit costs from the non-VA sector. If a cost function can be estimated from non-VA data, VA costs may be determined more economically from a reduced list of utilization items. If the analysis involves a new intervention or a program that is unique to VA, direct measurement of staff time and supplies may be needed. It is often sufficient to estimate the average cost of similar encounters, for example, the average of all hospital stays with the same diagnosis and same length of stay. Such estimates may be made by combining VA cost and utilization data bases and by applying judicious assumptions.
CONCLUSIONS: Assumptions used to estimate costs need to be documented and tested. VA cost-effectiveness research could be facilitated by the creation of a universal cost data base; however, it will not supplant the detailed estimates that are needed to determine the effect of clinical interventions on cost.

Entities:  

Mesh:

Year:  1999        PMID: 10217380     DOI: 10.1097/00005650-199904002-00003

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  9 in total

1.  Racial differences in well-being and cancer concerns in prostate cancer patients.

Authors:  Sumedha Chhatre; Alan J Wein; S Bruce Malkowicz; Ravishankar Jayadevappa
Journal:  J Cancer Surviv       Date:  2011-01-28       Impact factor: 4.442

2.  Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.

Authors:  Robert A Rosenheck; Douglas L Leslie; Kyaw J Sint; Haiqun Lin; Yue Li; Joseph P McEvoy; Matthew J Byerly; Robert M Hamer; Marvin S Swartz; T Scott Stroup
Journal:  Psychiatr Serv       Date:  2016-06-01       Impact factor: 3.084

3.  Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors.

Authors:  Ravishankar Jayadevappa; Stanley Bruce Malkowicz; Marsha Wittink; Alan J Wein; Sumedha Chhatre
Journal:  Health Serv Res       Date:  2012-03-14       Impact factor: 3.402

4.  Diagnostic cost groups (DCGs) and concurrent utilization among patients with substance abuse disorders.

Authors:  Amy K Rosen; Susan A Loveland; Jennifer J Anderson; Cheryl S Hankin; James N Breckenridge; Dan R Berlowitz
Journal:  Health Serv Res       Date:  2002-08       Impact factor: 3.402

5.  The impact of obesity on health care costs among persons with schizophrenia.

Authors:  Lydia A Chwastiak; Robert A Rosenheck; Joseph P McEvoy; T Scott Stroup; Marvin S Swartz; Sonia M Davis; Jeffrey A Lieberman
Journal:  Gen Hosp Psychiatry       Date:  2008-10-23       Impact factor: 3.238

6.  Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program.

Authors:  Robert Rosenheck; Douglas Leslie; Kyaw Sint; Haiqun Lin; Delbert G Robinson; Nina R Schooler; Kim T Mueser; David L Penn; Jean Addington; Mary F Brunette; Christoph U Correll; Sue E Estroff; Patricia Marcy; James Robinson; Joanne Severe; Agnes Rupp; Michael Schoenbaum; John M Kane
Journal:  Schizophr Bull       Date:  2016-01-31       Impact factor: 9.306

7.  Outcomes and cost-effectiveness of carpal tunnel injections using sonographic needle guidance.

Authors:  Tony Makhlouf; N Suzanne Emil; Wilmer L Sibbitt; Roderick A Fields; Arthur D Bankhurst
Journal:  Clin Rheumatol       Date:  2013-11-26       Impact factor: 2.980

8.  OnTrack Chile for people with early psychosis: a study protocol for a Hybrid Type 1 trial.

Authors:  Franco Mascayano; Iruma Bello; Howard Andrews; Diego Arancibia; Tamara Arratia; María Soledad Burrone; Sarah Conover; Kim Fader; Maria Jose Jorquera; Mauricio Gomez; Sergio Malverde; Gonzalo Martínez-Alés; Jorge Ramírez; Gabriel Reginatto; Alexandra Restrepo-Henao; Robert A Rosencheck; Sara Schilling; Thomas E Smith; Gonzalo Soto-Brandt; Eric Tapia; Tamara Tapia; Paola Velasco; Melanie M Wall; Lawrence H Yang; Leopoldo J Cabassa; Ezra Susser; Lisa Dixon; Rubén Alvarado
Journal:  Trials       Date:  2022-09-05       Impact factor: 2.728

9.  A non-pharmacologic approach to address challenging behaviors of Veterans with dementia: description of the tailored activity program-VA randomized trial.

Authors:  Laura N Gitlin; William C Mann; W Bruce Vogel; Paul B Arthur
Journal:  BMC Geriatr       Date:  2013-09-23       Impact factor: 3.921

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.